Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eugene McFadden

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 3, 2004
Elective sirolimus-eluting stent implantation for multivessel disease involving significant LAD stenosis: one-year clinical outcomes of 99 consecutive patients--the Rotterdam experienceChourmouzios A Arampatzis, Angela Hoye, Pedro A Lemos, et al.
Circulation|May 19, 2004
Post-sirolimus-eluting stent restenosis treated with repeat percutaneous intervention: late angiographic and clinical outcomesPedro A Lemos, Carlos A G van Mieghem, Chourmouzios A Arampatzis, et al.
REC, Interventional Cardiology|May 26, 2025
Use of cardiovascular registries in regulatory pathways: perspectives from the EU-MDR Cardiovascular CollaboratoryErnest Spitzer, José M de la Torre Hernández, Ingibjörg Jóna Guðmundsdóttir, et al.
Lancet (London, England)|September 7, 2012
Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trialEdoardo Camenzind, William Wijns, Laura Mauri, et al.
Coronary Artery Disease|April 21, 2004
Effectiveness of the sirolimus-eluting stent in the treatment of patients with a prior history of coronary artery bypass graft surgeryAngela Hoye, Pedro A Lemos, Chourmouzios A Arampatzis, et al.
Circulation|May 2, 2007
Clinical end points in coronary stent trials: a case for standardized definitionsDonald E Cutlip, Stephan Windecker, Roxana Mehran, et al.
The Journal of Invasive Cardiology|May 21, 2004
Effectiveness of the sirolimus-eluting stent in the treatment of saphenous vein graft diseaseAngela Hoye, Pedro A Lemos, Chourmouzios A Arampatzis, et al.
Circulation|March 3, 2004
Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) studyPedro A Lemos, Angela Hoye, Dick Goedhart, et al.
The American Journal of Cardiology|June 29, 2004
Effectiveness of sirolimus-Eluting stent implantation for coronary narrowings <50% in diameterAngela Hoye, Pedro A Lemos, Chourmouzios A Arampatzis, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 18, 2009
Drug-eluting stent implantation for chronic total occlusions: comparison between the Sirolimus- and Paclitaxel-eluting stentAngela Hoye, Andrew T L Ong, Jiro Aoki, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 3, 2004
Elective sirolimus-eluting stent implantation for multivessel disease involving significant LAD stenosis: one-year clinical outcomes of 99 consecutive patients--the Rotterdam experienceChourmouzios A Arampatzis, Angela Hoye, Pedro A Lemos, et al.
Circulation|May 19, 2004
Post-sirolimus-eluting stent restenosis treated with repeat percutaneous intervention: late angiographic and clinical outcomesPedro A Lemos, Carlos A G van Mieghem, Chourmouzios A Arampatzis, et al.
REC, Interventional Cardiology|May 26, 2025
Use of cardiovascular registries in regulatory pathways: perspectives from the EU-MDR Cardiovascular CollaboratoryErnest Spitzer, José M de la Torre Hernández, Ingibjörg Jóna Guðmundsdóttir, et al.
Lancet (London, England)|September 7, 2012
Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trialEdoardo Camenzind, William Wijns, Laura Mauri, et al.
Coronary Artery Disease|April 21, 2004
Effectiveness of the sirolimus-eluting stent in the treatment of patients with a prior history of coronary artery bypass graft surgeryAngela Hoye, Pedro A Lemos, Chourmouzios A Arampatzis, et al.
Circulation|May 2, 2007
Clinical end points in coronary stent trials: a case for standardized definitionsDonald E Cutlip, Stephan Windecker, Roxana Mehran, et al.
The Journal of Invasive Cardiology|May 21, 2004
Effectiveness of the sirolimus-eluting stent in the treatment of saphenous vein graft diseaseAngela Hoye, Pedro A Lemos, Chourmouzios A Arampatzis, et al.
Circulation|March 3, 2004
Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) studyPedro A Lemos, Angela Hoye, Dick Goedhart, et al.
The American Journal of Cardiology|June 29, 2004
Effectiveness of sirolimus-Eluting stent implantation for coronary narrowings <50% in diameterAngela Hoye, Pedro A Lemos, Chourmouzios A Arampatzis, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 18, 2009
Drug-eluting stent implantation for chronic total occlusions: comparison between the Sirolimus- and Paclitaxel-eluting stentAngela Hoye, Andrew T L Ong, Jiro Aoki, et al.
Pageof 7